Poly-MVA, Cancer, Stroke
In this video, Frank Antonawich spends about 23 minutes speaking on "Poly-MVA, Cancer, Stroke" at the 34th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Frank Antonawich
FRANK ANTONAWICH, Ph.D. completed his undergraduate training at the University of Rochester, New York, earned his Ph.D. in Neuroscience from New York University, and completed his post-doctoral fellowship in the Department of Neurology at Stony Brook University. He is a Professor of Biology at St. Joseph's College in New York, as well as the Chairman of the Biology Department. Dr. Antonawich serves as a Senior Scientist and the Clinical Research Administrator at Garnett McKeen Laboratory Inc., Bohemia, New York. His research focuses on the metabolic benefits and improved cellular effects of Palladium Lipoic Acid Complex (PolyMVA). His graduate Fellowship was conducted in the Department of Biology and Center for Neuroscience at New York University, where he studied the protective effects of peptides and hormones on brain injury and was awarded his Ph.D. in 1994. Dr. Antonawich was awarded the Charlotte Pann Award for the most outstanding Thesis, as well as the Gladys Mateko Award, presented to the top graduate student in the program. He continued at the University as an Adjunct Professor of Biology teaching Advanced Physiology and Neuroendocrinology courses in the Graduate School. In 1994, Dr. Antonawich was awarded a National Institute of Health Post Doctoral Fellowship in Neurology from the State University of New York at Stony Brook. From 1995–1997, he was awarded a second National Institute of Health Fellowship to study the programmed cell death (apoptosis) associated with stroke and ischemia. He continued his Neurodegeneration Work during his Post-Doctoral Fellowship in Dr. James Davis' Laboratory and became an Assistant Professor of Neurology in 1997 and taught in the Department of Pharmacology at Stony Brook. Dr. Antonawich has numerous publications in peer-reviewed Journals, and has written multiple chapters for books as well. His research over the past decade examines the role of cellular energy in the diseased states of cancer and stroke. This has led to his extensive studies using the unique dietary supplement Poly-MVA. Its most active ingredient is a Palladium Lipoic Acid Complex (PdLA) where the element palladium is bound to the anti-oxidant alpha-lipoic acid resulting in a potent anti-oxidant and energy facilitating formulation. His ishemia/stroke studies have demonstrated that acute, post-ischemic and prophylactic administration of Poly-MVA limits ischemic damage. Furthermore, due to the metabolic dysfunction of cancer cells, Poly-MVA's energy initiates cell death in malignant cells.
Transcription
All right, first, I would like to apologize. Actually, I'm feeling a lot better. Thank you, Bill, for helping me. I had a US laryngitis the last two days, and I was very nervous on the plane. If I could keep my mouth shut for six hours, that I would be able to speak at the conference. So I'm Dr. Frank Antonovich. I'm currently now at Garnette McKean Labs. I just left Stony Brook University after 12 years, working day in and day out with Dr. Merrill, guard at the inventor of Pawley MBA. And today, I'd like to talk about my work with cancer and stroke. Also, some additional information on this will be available tomorrow morning at a free breakfast at six five on Polli MBA. So I encourage everyone with the advancements in heart disease, cancer, as you all know, in this room, has now surpassed. Heart disease is the number one leading cause of death in the U.S. and there are about over a half a million people each year old die from cancer.
This is just taken recently from the American Kansas Society's Web site showing the continuing increasing trend. Any incidence of cancer in the United States, even with the major advances Big Pharma has made or they claim to have made these transits, you still look at the blow up to the right here. Still increasing the slope of increase, increasing incidents of cancer. This is also from the American Cancer Society showing the incidents in men and women of new cancers that occur and the percentages of each type with one third being prostate men and a third breast in women.
Now, today, as I mentioned, I'm going to spend most of my time focusing on cancer because it's the Cancer Control Society meeting. But you can't stroke is the number three leading cause of death in this country. And it's the number one leading cause of long term disability in the United States of 4.5 million. Survivors of stroke are alive today. But fifty one billion dollars are lost in productivity and medical costs each year due to stroke.
Now, the big question that everyone sitting in this room is probably going to say is, what did these things have in common and why would Polli NBA kill cancer cells? But at the same time be a benefit to a scheme excels. Ischemia means an interruption of blood flow. A person could have a brief interruption of blood flow that's referred to as a TIAA or a transient ischemic event, or they can have a prolonged blockage of blood flow resulting in a stroke. But the big did similarity between these